BackSMS Pharmaceuticals Limited Overview

SMS Pharmaceuticals Limited Receivables

Track SMS Pharmaceuticals Limited's receivables ($2.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.43B
↑ 9.88% YoYΔ $218.69M vs prior year quarter

Peer trimmed avg / median

Loading

SMS Pharmaceuticals Limited Receivables History

Loading

SMS Pharmaceuticals Limited vs. peers: Receivables Comparison

Loading

SMS Pharmaceuticals Limited Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

SMS Pharmaceuticals Limited (SMSPHARMA.BO) FAQ

SMS Pharmaceuticals Limited posts a receivables of $2.4B as of September 2026. That compares with $2.2B in the prior-year period — up 9.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, SMS Pharmaceuticals Limited's receivables was $2.2B. The latest reading is $2.4B — a 9.9% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of SMS Pharmaceuticals Limited's financial statement story. At $2.4B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SMSPHARMA.BO's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; SMS Pharmaceuticals Limited's other metric pages and overview cover the third.